Product
TGRX-1942
1 clinical trial
3 indications
Indication
Lung CancerIndication
Advanced Solid TumorIndication
hematologic malignanciesClinical trial
A Dose Escalation and Expansion Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TGRX-1942 in Patients With Advanced Solid Tumor and/or Relapsed/Refractory Hematologic MalignanciesStatus: Not yet recruiting, Estimated PCD: 2026-12-31